 |
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
U.S. Centers for Disease Control and Prevention
• News Briefs
Australian-Developed HIV Vaccine Trial AnnouncedJune 4, 2003 This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document. In Sydney today, the Australian-Thai HIV Vaccine Consortium announced that recruitment of volunteers has begun for the first clinical trials of a new Australian-developed HIV vaccine. The trial, to take place at Sydney's St. Vincent's Hospital, will involve 24 HIV-negative volunteers. "We will be able to undertake a range of sophisticated laboratory tests to determine if the vaccines stimulate the human immune system to produce anti-HIV responses," said principal investigator Dr. Tony Kelleher of the University of New South Wales. The vaccine is based on "prime and boost" technology, which combines modified HIV DNA with a fowl pox virus. Results are expected by the end of the year. The trial is funded by a grant from the U.S. National Institutes of Health and the Australian government.
Back to other CDC news for June 4, 2003 This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document. Australian Associated Press 06.04.03 This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
|
E-Mail
Printable Single-Page
Glossary
Share
